sophocarpine has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F; Chen, YX; Li, ZS; Qiao, CP; Wang, PQ; Xie, WF; Yuan, ZL; Zhang, JP; Zhang, PP; Zhang, Q; Zhang, X | 1 |
1 other study(ies) available for sophocarpine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Differentiation therapy of hepatocellular carcinoma by inhibiting the activity of AKT/GSK-3β/β-catenin axis and TGF-β induced EMT with sophocarpine.
Topics: Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Catenins; Cell Differentiation; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3 beta; Humans; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Phenotype; Proto-Oncogene Proteins c-akt; Signal Transduction; Spheroids, Cellular; Time Factors; Transforming Growth Factor beta; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |